SANTA CLARA, Calif.–(BUSINESS WIRE)–Sep 25, 2020–
Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing. Mary will be responsible for driving the development and implementation of global marketing strategies and initiatives that support commercialization of its Shape Memory Polymer embolization products and therapies.
Mary brings over 20 years of medical device experience with organizations ranging from early stage start-ups to established global market leaders in the cardiovascular and orthopedic spine industries. Mary recently spent seven years at Endologix as Director of Global Marketing and later as Senior Director of Clinical Marketing and Health Economics with a focus on market development for the company’s aortic endovascular therapies. Prior to these roles, Mary held senior-level product and corporate marketing positions in the U.S. and abroad at Kyphon (acquired by Medtronic) and Guidant Vascular Intervention (acquired by Abbott Vascular). Mary’s marketing career also includes Syntactx, a premier global clinical research organization, and the world-renowned Arizona Heart Institute.
“As we continue to grow as an emerging global leader in therapies for peripheral embolization, hemorrhagic aneurysms and endovascular aortic aneurysms, Mary’s broad leadership and experience will help make that vision a reality,” said Ted Ruppel, President and Chief Executive Officer of Shape Memory Medical Inc. “Mary’s proven background in market development, product launch, and communications will be crucial to our successful market growth. She also comes to us with a long history of collaborative relationships within the vascular community that will enable us to further advance our product development and clinical research initiatives.”
“I am very excited to join the Shape Memory Medical team and to be a part of an organization with such an innovative and unique portfolio,” said Mary of her new position. “I truly believe that our technology has great potential to address several unmet clinical needs, and I am particularly excited about our clinical work in the aortic aneurysm space. We announced last week the initiation of the prospective AAA-SHAPE study looking at the use of the IMPEDE-FX Embolization Plug to treat the abdominal aortic aneurysm sac during traditional EVAR procedures, and I look forward to working together with the physician community along this journey.”
Mary earned a Bachelor of Science degree from Penn State University, a Master of Business Administration from the Franciscan University of Steubenville, and a Master of Health Administration from the University of Phoenix.
About Shape Memory Medical
Shape Memory Medical Inc., based in Santa Clara, California, is dedicated to developing innovative therapeutic solutions with its proprietary Shape Memory Polymers. Neurovascular embolization products include the TrelliX® Embolic Coil; CE marked for use in the EU. Peripheral embolization products include the IMPEDE® and IMPEDE-FX Embolization Plugs; both CE marked for use in the EU and cleared for use in the United States (US). In the United States, the IMPEDE-FX Embolization Plug is currently indicated for use with the IMPEDE Embolization Plug to obstruct or reduce the rate of blood flow in the peripheral vasculature. In countries recognizing CE marking, the IMPEDE-FX Embolization Plug is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature. For more information, visit www.shapemem.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200925005059/en/
CONTACT: Mary Dennehy
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH CARDIOLOGY MEDICAL DEVICES
SOURCE: Shape Memory Medical Inc.
Copyright Business Wire 2020.
PUB: 09/25/2020 10:00 AM/DISC: 09/25/2020 10:01 AM